Kesha Patel is a Research Associate II in Protein Engineering at Zymeworks Inc., where they focus on advancing drug design and discovery. They hold a Master of Science in Biochemistry from McGill University and previously completed a Bachelor of Pharmacy at Charotar University of Science and Technology. Their research expertise includes identifying inhibitors for DEAD-box RNA helicases in relation to cancer progression, and they possess competencies in protein expression, purification, and early drug discovery. Kesha has also gained experience in quality assurance and control during a prior role at LINK PHARMA CHEM LTD. and engaged in analytical method development during a summer research fellowship.